Table 4.
Summary of European studies regarding the prevalence of HPV in women with cytological abnormalities
| Authors (Year) | Citation | N (Country) | Method of Analysis | HPV+ (%) |
|---|---|---|---|---|
| Bonde et al. (2014) | [7] | 5068 (Denmark) | CLART | 88.9% |
| Capra et al. (2008) | [19] | 970 (Italy) | Nested PCR/sequencing INNO-LiPA | 37.7% |
| Delgado et al. (2012) | [20] | 106 (Spain) | Linear Array | 69.8% |
| Meloni et al. (2014) | [21] | 650 (Italy) | INNO-LiPA | 52.6% |
| Monsonego et al. (2008) | [22] | 575 (France) | Linear Array Hybrid Capture II |
88.1% |
| Panotopoulou et al. (2007) | [23] | 997 (Greece) | PCR/sequencing | 75.1% |
| Rassu et al. (2005) | [24] | 1335 (Italy) | PCR-RFLP | 35.3% |
| Simanaviciene et al. (2015) | [25] | 547 (Lithuania) | PCR | 67.6% |
| Spinillo et al. (2009) | [26] | 1218 (Italy) | INNO-LiPA | 69.9% |
| Yapijakis et al. (2008) | [27] | 263 (Greece) | PCR-RFLP | 81.7% |